+
Site Tour

N. Van Mieghen "Navitor™ is a device iteration that really has changed the way we do our implantation"

Discover what N. Van Mieghem, M. Van Wely, L. Testa, M. Taramasso and M. Mullen think about Navitor™ stable delivery

Related Videos

Now you've got Navitor. Remarkable performance.

Now you've got Navitor.
Future ready.

TAVI Summit - Live case from Berlin

TAVI 2023: Optimizing TAVI

TAVI 2023: The next level

TAVI Summit - PreTAVR CT analysis

LAAO Summit 2023: Leaks/DRT

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

EuroPCR 2023: Vascular access

TAVI Summit - Cardiac imaging

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

EuroPCR - TAVI : lifetime management VISION

Anatomical overview of the AV Valves

PCR LV 23 - Clinical practice for TAVI

PremiClose 2024: Optimizing care

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Valvular Plug III – Patients

bRIGHT study

Epic Mitral – 10-Year Clinical Outcomes

EXPAND Study: Data overview

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline